0000899243-23-012178.txt : 20230503
0000899243-23-012178.hdr.sgml : 20230503
20230503211611
ACCESSION NUMBER: 0000899243-23-012178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WELCH DANIEL G
CENTRAL INDEX KEY: 0001206199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23886082
MAIL ADDRESS:
STREET 1: 4611 UNIVERSITY DR
STREET 2: 4 UNIVERSITY PLACE
CITY: DURHAM
STATE: NC
ZIP: 27707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-01
0
0001060736
Seagen Inc.
SGEN
0001206199
WELCH DANIEL G
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
1
Common Stock
2023-05-01
4
M
0
5150
64.38
A
12049
D
Common Stock
2023-05-01
4
S
0
5150
200.04
D
6899
D
Common Stock
2023-05-01
4
M
0
1990
56.77
A
8889
D
Common Stock
2023-05-01
4
S
0
1990
200.12
D
6899
D
Common Stock
2023-05-01
4
S
0
295
200.06
D
6604
D
Common Stock
2023-05-01
4
S
0
4890
200.06
D
18170
I
by Trust
Common Stock
2023-05-02
4
M
0
1888
64.38
A
8492
D
Common Stock
2023-05-02
4
S
0
1888
200.05
D
6604
D
Common Stock
2023-05-02
4
M
0
3171
160.33
A
9775
D
Common Stock
2023-05-02
4
S
0
3171
200.05
D
6604
D
Common Stock
2023-05-02
4
M
0
3462
147.50
A
10066
D
Common Stock
2023-05-02
4
S
0
3462
200.10
D
6604
D
Common Stock
2023-05-02
4
S
0
351
200.07
D
6253
D
Common Stock
2023-05-02
4
S
0
5835
200.07
D
12335
I
by Trust
Non-Qualified Stock Option (right to buy)
56.77
2023-05-01
4
M
0
1990
0.00
D
2028-05-18
Common Stock
1990
0
D
Non-Qualified Stock Option (right to buy)
64.38
2023-05-01
4
M
0
5150
0.00
D
2029-05-20
Common Stock
5150
1888
D
Non-Qualified Stock Option (right to buy)
64.38
2023-05-02
4
M
0
1888
0.00
D
2029-05-20
Common Stock
1888
0
D
Non-Qualified Stock Option (right to buy)
160.33
2023-05-02
4
M
0
3171
0.00
D
2030-05-15
Common Stock
3171
0
D
Non-Qualified Stock Option (right to buy)
147.50
2023-05-02
4
M
0
3462
0.00
D
2031-05-14
Common Stock
3462
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.03 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.05 to $200.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.16 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested in full on 5/18/19.
Options vested in full on 5/20/20.
Options vested in full on 5/15/21.
Options vested in full on 5/14/22.
By: /s/ Jennifer Prosba For: Daniel G. Welch
2023-05-03